19AQMM26F1521 - Sole Source Justification Under Federal Supply Schedule: 20262027 Flu vaccines

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

ACQUISITIONS - AQM MOMENTUM

Contract Value

Not provided

Codes & Classification
Solicitation Number

19AQMM26F1521

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

Durham, North Carolina, UNITED STATES

SourceSAM
Documents1
The Department of State, through its Acquisitions - AQM Momentum office, has issued a sole-source justification for the annual procurement of influenza vaccines under Federal Supply Schedule contract number 36F79722D0178. This delivery order is placed with the Department of Veterans Affairs’ GlaxoSmithKline federal supply schedule, specifically for proprietary Fluarix and Flulaval Influenza vaccines. The procurement is classified under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and product service code 6505, indicating drugs and biologicals. The primary objective of this procurement is to secure a reliable supply of flu vaccines for the 2026-2027 season, ensuring timely and effective immunization for personnel at the designated place of performance: Durham, North Carolina. The scope of the contract encompasses the annual delivery of these vaccines, leveraging the federal supply schedule to obtain products that are proprietary to GlaxoSmithKline, thereby necessitating a sole-source approach. Key requirements include the provision of Fluarix and Flulaval vaccines, both of which are recognized for their efficacy in preventing influenza. The expected deliverables are the timely supply and distribution of these vaccines to the specified location, supporting the Department of State’s health and safety objectives. This procurement is a sole-source delivery order, meaning it is not open to competition due to the proprietary nature of the vaccines and the established federal supply schedule relationship. There are no set-aside requirements or special considerations indicated in the notice, and the contract is managed at the federal office level. The contracting entity is the Acquisitions - AQM Momentum office within the Department of State, with Lesley A. Stewart serving as the primary contact for this opportunity. Interested parties may reach out via email at [email protected] for further information. The notice remains active and can be accessed through the SAM.gov portal using Opportunity ID 7b22f9e4f4554a2d99e95e46286847c7. Contractors evaluating this opportunity should note that the procurement is limited to the specified proprietary vaccines and is executed under a sole-source justification, reflecting the Department’s commitment to securing high-quality, reliable pharmaceutical products for its annual immunization program in Durham, North Carolina.